Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
pharmaphorum8d
California sues insulin producers and PBMs over pricing
Last year, non-profit drugmaker Civica Rx pledged to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog, and Lilly's Humalog – by 2024.
pharmaphorum5mon
Patients resist Novo Nordisk plan to stop making Levemir
Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin glargine) and biosimilars and Novo Nordisk's newer product Tresiba ...
What consumers should know about the FTC’s upcoming lawsuit against CVS over how it negotiates drug prices
But Sanofi’s Lantus costs $292 per vial, Nordisk’s NovoLog listed theirs for $289, and Eli Lilly’s Humalog for $66.40. Novo ...
Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
Medscape3d
Room-temperature Storage of Medications Labeled for Refrigeration
injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% ...